Molecular Biotechnology is a dynamic field that revolves around the manipulation of biological molecules at the molecular and genetic levels. At its core, it involves the application of molecular biology techniques to solve problems and create innovative solutions. This interdisciplinary field combines principles from biology, chemistry, and genetics to understand and modify biological systems.
Researchers in molecular biotechnology work with DNA, RNA, proteins, and other molecular components to develop new technologies, diagnose diseases, and create novel therapies. Techniques such as genetic engineering, polymerase chain reaction (PCR), and recombinant DNA technology are pivotal in this field. Molecular biotechnology has broad applications, including the production of recombinant proteins, gene therapy, and the study of genetic disorders.
As technology advances, molecular biotechnology continues to evolve, offering unprecedented opportunities for understanding and manipulating the building blocks of life. This field stands at the forefront of scientific and medical advancements, driving progress in areas like personalized medicine, biopharmaceuticals, and genetic engineering. Ethical considerations and responsible use of molecular biotechnology are integral components of its ongoing development. Applications of molecular biotechnology are widespread, ranging from the production of biofuels and pharmaceuticals to the diagnosis and treatment of genetic diseases. As our understanding of molecular mechanisms deepens, molecular biotechnology continues to drive innovations that shape the future of various scientific and industrial domains.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia